分化型甲状腺癌18F-FDG PET显像的临床应用

Application of 18F-FDG PET scan in patients with differentiated thyroid cancer

  • 摘要: 低分化型甲状腺癌细胞摄取碘能力的下降或丧失导致131IWBS(全身显像)假阴性(约20%),高水平的血清Tg(甲状腺球蛋白)只能说明有分化型甲状腺癌(DTC)的复发或转移,不能确定DTC复发或转移的具体位置,而低分化型甲状腺癌正是DTC病人死亡的主要类型。本文主要探讨18F-FDG(18F-氟代脱氧葡萄糖)PET显像在131I的WBS阴性而血清Tg水平增高的DTC病人中鉴别复发和转移的应用以及评价DTC病人预后的价值,当嗜18F-FDG肿瘤显示的体积大于125mL或FDG标准摄取值大于10g/mL时,病人的预后不良。

     

    Abstract: Poorly differentiated thyroid cancer lesions often lose the ability to concentrate radioactive 131I iodine and exhibit increased metabolic activity, as evidenced by enhanced glucose uptake.18F-FDG PET was able to localize residual and metastatic thyroid cancer lesions in patients with negative diagnostic 131IWBS and elevated serum thyroglobulin levels, although it uas not sensitve enough to detect mivimal metastatic disea in cervical nodes.multivariate analysis demonstrated that the single strongest predictor of survial was the volume of FDG-avid disease.Subjects with a FDG volume greater than 125mL or with SUV greater than 10g/mL have significantly reduced short survival.

     

/

返回文章
返回